








DSM appoints new President DSM Nutritional Products


September 20, 2012 07:43 ET
DSM appoints new President DSM Nutritional Products
HEERLEN, NETHERLANDS--(Marketwire - Sep 20, 2012) -
Royal DSM, the global Life Sciences and Materials Sciences company, today announces the following:
Chris Goppelsroeder, (1959), currently Global Head of the Seed Care business of Syngenta, a Swiss based global agribusiness leader, will join DSM on January 1, 2013 as President and CEO, DSM Nutritional Products, reporting to Stephan Tanda, Member of the Managing Board of DSM and responsible for the Nutrition cluster.
Chris will succeed Leendert Staal, currently President and CEO of DSM Nutritional Products, who after a very successful career of 10 years at DSM, will retire at the end of February, 2013. Leendert has made tremendous contributions to the company, first in DSM Pharmaceutical Products, later at DSM Nutritional Products, which he built into a strong, global and highly successful organization and industry leader.
Chris, a Swiss national, was a member of the Managing Board of DSM from 2005 to 2006, prior to his current position at Syngenta. During that period, he was responsible for a number of businesses in the Performance Materials and Industrial Chemicals clusters and also had corporate responsibility for Marketing and for the regions Europe and Japan. He left for family reasons.
Chris came to DSM through the acquisition of the Roche Vitamins and Fine Chemicals Business where he spent a considerable part of his career, based in Switzerland, Belgium and the USA, building significant international experience in the life sciences industry.
DSM - Bright Science. Brighter Living.™
Royal DSM N.V. is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 22,000 employees deliver annual net sales of about EUR 9 billion. The company is listed on NYSE Euronext. More information can be found at [ www.dsm.com ]
Chris Goppelsroeder-jpg: [ http://hugin.info/130663/R/1642313/529028.jpg ]
Press release-pdf: [ http://hugin.info/130663/R/1642313/529026.pdf ]
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DSM N.V. via Thomson Reuters ONE [HUG#1642313]